Key result
Early application of a high-flow nasal cannula will be evaluated against conventional low-flow oxygen therapy for its effect on the 72-hour reintubation rate in a planned randomized trial of 260 surgical ICU patients following prolonged general anesthesia.
Why the study?
Does high-flow nasal cannula reduce the reintubation rate in early post-extubation adult patients following prolonged general anesthesia for non-cardiothoracic and non-neuro surgery?
RCT (n=260)
1:1 ratio with variable block sizes and concealed envelopes
No
Does high-flow nasal cannula reduce the reintubation rate in early post-extubation adult patients following prolonged general anesthesia for non-cardiothoracic and non-neuro surgery?
This protocol outlines a trial to determine if high-flow nasal cannula reduces reintubation rates compared to low-flow oxygen in high-risk surgical ICU patients after prolonged general anesthesia.
Background: The main concerns following general anesthesia, especially if it lasts longer than 4 hours, are postoperative pulmonary complications, including hypoxemia, lung atelectasis, and acute respiratory failure requiring reintubation. To avoid these complications, postoperative extubation with respiratory support is crucial. The high-flow nasal cannula (HFNC) increases end-expiratory lung volume and reduces the work of breathing to improve oxygenation by delivering a flow-dependent positive airway pressure. The advantages of using HFNC to prevent reintubation have been demonstrated in patients undergoing cardiothoracic surgery. Our target population's information is still deficient, and our trial is set up to uncover this proof. Objectives: To evaluate the effect of high-flow nasal cannula (HFNC) versus low-flow nasal cannula on the reintubation rate and clinical outcomes in the early post-extubation adult who has prolonged general anesthesia for non-cardiothoracic and non-neuro surgery that requires surgical ICU admission. Methods: In this study, 260 patients with an intermediate to high risk of postoperative pulmonary complications following non-cardiothoracic surgery and non-neurosurgery that required general anesthesia for longer than 4 hours were randomly assigned to receive either a high-flow nasal cannula (HFNC) or a low-flow nasal cannula after extubation. The primary outcome indicator is the reintubation rate within 72 hours of tracheal extubation. Postoperative pulmonary complications, the length of stay in the ICU and hospital, and mortality are considered secondary outcome measures. Conclusions: This study is an investigator-initiated randomized controlled trial powered to test the hypothesis that early application of a high-flow nasal cannula probably reduces the reintubation rate in patients in SICUs with prolonged durations of general anesthesia.
No takes yet. Share an insight, caveat, or question.
Phetuthairung et al. (2023) conducted an RCT in Postoperative pulmonary complications after prolonged general anesthesia (n=260). High-flow nasal cannula (HFNC) vs. Conventional low-flow oxygen therapy (3-5 L/min) was evaluated on Reintubation rate within 72 hours of tracheal extubation. Early application of a high-flow nasal cannula will be evaluated against conventional low-flow oxygen therapy for its effect on the 72-hour reintubation rate in a planned randomized trial of 260 surgical ICU patients following prolonged general anesthesia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: